mesothelioma cancer mesothelioma lawyer mesothelioma treatment mesothelioma symptoms mesothelioma news

 
 
 


 
 

Yahoo! News Search Results for mesothelioma
      

  1. New Research Could Help Provide Answers To Mesothelioma, England (Medical News Today)
    Tue, 09 Mar 2010 11:31:57 GMT
    The British Lung Foundation is working with the June Hancock Mesothelioma Research Fund to support new research which could lead to better treatments for mesothelioma, an incurable asbestos-related cancer that affects the tissues lining the outside of the lung and the chest wall (pleura). Following a competitive grant application process, Dr Stefan Marciniak at the UniversityofCambridge was ...
  2. New Research May Help Predict Post-Surgery Survival Rate For Mesothelioma Patients (PRWeb via Yahoo! News)
    Tue, 09 Mar 2010 07:01:00 GMT
    New York attorney Joseph W. Belluck, who handles mesothelioma cases, says study may give patients and their families a more accurate prognosis of the disease and how post-surgical patients will likely respond.
  3. Spate of class-action lawsuits casts light on system (The Springfield News-Leader)
    Wed, 10 Mar 2010 09:46:38 GMT
    Class-action lawsuits have been in the news lately, but while commercials seeking mesothelioma patients or birth defects are all over TV, such lawsuits are relatively rare locally.
  4. New anti-tumour vaccine for mesothelioma shows promising results (News-Medical-Net)
    Sat, 06 Mar 2010 04:55:12 GMT
    A vaccine against mesothelioma, a cancer associated with exposure to asbestos, has shown early promise in its first clinical trial.
  5. Possible Vaccine For Mesothelioma Proven Safe (Medical News Today)
    Fri, 05 Mar 2010 09:46:44 GMT
    Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient's own dendritic cells (DC) with antigen from the patient's tumor, was able to induce a T-cell response against mesothelioma tumors. "[This] is the first human study on DC-based immunotherapy in patients with ...